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ABSTRACT 
Cataract surgery is one of the most common surgical procedures performed worldwide. 
Posterior capsul  opacification (PCO) remains the most common postoperative complication 
that can deteriorate vision. Development of glistenings in the artificial intraocular lens (IOL) 
after cataract surgery is a phenomenon with the potential to reduce the outcome of an 
otherwise excellent final surgical result. Phacoemulsification has been the most common 
surgical technique performed to remove cataracts during the previous 25 years. The settings 
controlling the fluidics in the eye intraoperatively can affect the postoperative convalescence. 
Since many people undergo cataract surgery annually and all of the previously 
mentioned issues can affect the final outcome, a better understanding and more studies 
comparing different IOLs and phacoemulsification settings will help surgeons choose better 
IOLs and surgical techniques and decrease postoperative complications. 
In study I, we compared the development of PCO and glistenings associated 
with two hydrophobic acrylic IOLs, the Sensar AR40e (Abbott Medical Optics) and AcrySof 
SA60AT (Alcon), 5 to 7 years after cataract surgery. Both IOLs had a sharp posterior edge 
design. We also evaluated if there were correlations between the amount of glistenings and 
corrected distance visual acuity (CDVA) or contrast sensitivity and if subjective gradings of 
glistenings were correlated with the objective quantification of glistenings with Scheimpflug 
images. Eighty patients were included in this prospective randomized study. Fifty-six patients 
completed the follow-up visit from 5 to 7 years postoperatively. Glistenings were graded at 
the slit-lamp microscope and the amount of glistenings was quantified objectively using 
Scheimpflug images with subsequent processing in computer software. There were no 
significant differences in PCO area and severity or neodymium:yttrium-aluminium-garnet 
(Nd:YAG) capsulotomy rates between the IOLs. Significantly more glistenings were found in 
the AcrySof hydrophobic IOLs 5 to 7 years postoperatively. The glistenings were not 
correlated with the CDVA or contrast sensitivity. 
In study II, we evaluated in a prospective randomized trial if there were any 
correlations between the amount of glistenings and CDVA or contrast sensitivity and 
compared the development of glistenings in two acrylic IOLs, a hydrophilic IOL (BL27, 
Bausch & Lomb) and a hydrophobic IOL (AcrySof SA60AT), 9 years after cataract surgery. 
One hundred and twenty patients were recruited, 78 completed the 9-year follow-up visit.  
e
  
The amount of glistenings was quantified objectively using Scheimpflug 
images with subsequent processing in computer software. Glistenings were also subjectively 
graded at the slit-lamp microscope. The hydrophobic IOL had significantly more glistenings 
at the 9-year follow-up visit. The glistenings were not correlated with the CDVA or contrast 
sensitivity. 
In study III, we compared the PCO area, severity, and survival time without 
Nd:YAG capsulotomy between a hydrophilic (BL27) and a hydrophobic (AcrySof SA60AT) 
acrylic IOLs 9 years after cataract surgery. One hundred and twenty patients were recruited, 
78 completed the 9-year follow-up visit. The PCO area and severity were higher in the 
hydrophilic IOL. The survival time without Nd:YAG capsulotomy was longer in the 
hydrophobic IOL. 
In study IV, we compared low and standard fluidics settings during 
phacoemulsification cataract surgery and evaluated the impact on the eye postoperatively by 
measuring parameters indicating surgical trauma. Forty-three patients were recruited and 
randomized into two groups, i.e., those that underwent phacoemulsification with low or 
standard fluidics settings. The central corneal thickness, macular thickness, and intraocular 
pressure were measured preoperatively, 1 day, 3 weeks, and 3 months postoperatively. The 
CDVA was measured preoperatively, 3 weeks and 3 months after surgery. Anterior chamber 
flare was measured preoperatively, 1 day and 3 weeks postoperatively. Endothelial cell 
density was measured preoperatively and 3 months postoperatively. The low-settings group 
had a significantly longer surgical time and higher amount of ultrasound energy used 
intraoperatively, but there were no significant differences in the outcome parameters between 
the two groups. 
In conclusion, significantly more glistenings developed in the AcrySof 
hydrophobic IOLs 5 to 7 years postoperatively compared to the hydrophobic Sensar IOL. The 
glistenings were not correlated with the CDVA or contrast sensitivity. The hydrophobic 
AcrySof IOL developed significantly more glistenings at the 9-year follow-up visit compared 
to the hydrophilic BL27 IOL. The glistenings were not correlated with the CDVA or contrast 
sensitivity. The PCO area and severity were higher in the hydrophilic IOL. The survival time 
without Nd:YAG capsulotomy was longer in the hydrophobic IOL. Phacoemulsification 
surgery with low fluidic settings rendered significantly longer surgical time and higher 
amount of ultrasound energy used intraoperatively, but there were no significant differences 
in the outcome parameters between the two groups.  
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1 LENS GLISTENINGS 
1.1 INTRODUCTION 
Glistenings were first reported in polymethyl methacrylate (PMMA) intraocular lenses 
(IOLs)1. However, it was after the introduction of the popular hydrophobic acrylic AcrySof 
IOL (Alcon) in 1994 that glistenings caught the attention of clinical researchers, who then 
began investigating if this phenomenon had any substantial clinical impact on vision.  
 
1.2 DEFINITION 
Glistenings are defined as fluid-filled microvacuoles that form within the IOL when it is in an 
aqueous environment2. 
 
1.3 GLISTENING FORMATION, ONSET, AND SIZE 
The formation process of lens glistenings remains controversial. Two theories have been 
proposed. The first theory suggests that formation of microvoids inside the IOL material 
occurs during the polymerization process in one of the IOL production steps. The microvoids 
slowly absorb water when the IOL is in the aqueous environment. When water vapor 
detaches from the surrounding matter inside the microvoids, a reaction called phase 
separation occurs. Because there are differences in the refractive indices between water and 
the surrounding IOL material, light scatters when it passes between the two media and 
appears as sparkling dots, hence, the term glistenings2.  
 The water absorption rate differs between different IOLs and the surrounding 
environment regarding temperature3 and osmotic level4. Different IOLs have different glass 
transition temperatures (Tgs). When the temperature is above the Tg, the IOL absorbs water 
faster and is soft and flexible. Below the Tg, the IOL is rigid and the water absorption rate is 
slower. Hydrophobic acrylic IOLs have Tgs close to room temperature, 20 Cº for the 
hydrophobic AcrySof IOL. A temperature below 15°C has not been associated with 
glistening formation in the most commonly implanted IOLs5. 
In vitro experiments in which IOLs were exposed to temperature variations, 
mimicking accelerated glistening formation that could take years in vivo, showed that when 
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the IOLs are suspended in an aqueous environment and heated, the IOLs become 
oversaturated with water. However, after cooling, causing phase separation in the microvoids 
of the IOLs, glistenings are observed because of the difference in the refractive indices 
between water and the surrounding IOL material as mentioned previously. 
The second theory suggests that as hydrophilic impurities enter the microvoids 
inside the IOL material, the osmotic gradient inside the voids increases from the surrounding 
aqueous environment, causing an influx of water through diffusion with subsequent 
expansion of the microvoids. When a critical level of expansion is reached, probably causing 
cracks and tears in the IOL material surrounding the microvoids, they become permanent4. 
Repeated heating and cooling of the IOL showed that glistenings appear at the same locations 
in the IOL6. 
Glistenings can develop as soon as 1 week after cataract surgery7 in sizes 
ranging from 1 to 20 microns6 8-10, often 1 to 10 microns in clinical cases. In vitro studies with 
more extreme environmental variations can generate glistenings with sizes up to 20 micron or 
larger. 
 
1.4 FACTORS AFFECTING GLISTENING FORMATION 
Different IOL materials, hydrophilic, hydrophobic, PMMA, and silicone IOLs have been 
identified to develop glistenings to different degrees7 11-13. Time is also crucial; the longer 
time that has passed since IOL implantation the more likely it is that glistenings will develop 
or the number of existing glistenings will increase13-16. 
The IOL dioptric power17, IOL packaging18, IOL manufacturing technique19, 
temperature changes6, glaucoma20, uveitis and other conditions with breakdown of the blood-
aqueous barrier21, use of antiglaucoma eye drops,20 22 and anti-inflammatory eye drops 
containing surfactant may have a role in glistenings formation23 24. 
When the AcrySof hydrophobic acrylic IOL was introduced to the market in 
1994, it was delivered packed in the AcryPak system, containing both the IOL and a folder in 
a plastic case that was sterilized in the plastic case. One of the first reports of glistenings in 
AcrySof IOLs was associated with this IOL packaging system. The increased glistenings in 
the IOLs in the AcryPak compared to the same IOLs in the so-called Wagon Wheel packages 
led to the conclusion that the microenvironment in the AcryPak system was changed and 
hence the development of glistenings increased18. 
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The production of IOLs is divided into two principal techniques: cast molding 
and lathe-cutting. The former is suitable for large quantity production and involves 
polymerization of IOL monomer mixtures in casting molds. Parts of heterogeneous unreacted 
monomers can still be present in the molds and may explain why in some studies there are 
more glistenings in IOLs produced with cast molding compared to lathe-cutting19.  
The latter, lathe-cut IOLs, are produced from mixtures of monomers 
polymerized into large acrylic sheets and IOLs from homogenous parts of the sheet are 
subsequently cut out from the sheet and polished.  
 
1.5 METHODS TO ASSESS AND GRADE GLISTENINGS 
Glistenings can be graded in two ways. Most commonly subjective grading systems of 0 to 
325 and 0 to 4 have been used7 14 26 27, with 0 representing no glistenings, 1 trace, 2 minor, 3 
moderate, and 4 severe. The examiner grades the glistenings based on how many glistenings 
the IOL appears to have under slit-lamp microscopy. To grade glistenings objectively and 
facilitate quantitative comparisons between studies and reproduction of the results, Professor 
Behndig invented a method of analyzing glistenings performed with Scheimpflug images13 14 
23 28 29.  
The Scheimpflug technique uses the ability to rotate around the visual axis and 
scan the IOL at different angles, capturing optical sections with the camera’s charge-coupled 
device sensor. When two two-dimensional sections of images perpendicular to each other are 
used in the subsequent analysis with computer software, they produce a three-dimensional 
image. The amount of reflected light scattering is measured in computer compatible tape 
(CCT) with 256 levels of brightness, ranging from 0 for black to 255 for white. Within this 
three-dimensional image, the CCTs represent glistenings and are calculated with computer 
software. Images of light scatterings in the IOLs are illustrated in figure 1.  
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1.6 PROGRESSION OVER TIME 
Several studies, some of which were long term, have reported that glistenings progress over 
time in all IOLs7 13, but especially in the hydrophobic acrylic AcrySof IOLs7 12-15. However, 
some studies have reported that glistenings tend to stabilize after a certain time10 20. 
In a study7 with up to a 2-year follow-up, the earliest glistenings were observed 
as early as 1 week after cataract surgery and increased thereafter up to 90 days. After 180 
days, the amount of glistenings in all IOLs included in the study (2 silicone, 3 hydrophilic 
acrylic, and 2 hydrophobic acrylic) stabilized; however, in the AcrySof (hydrophobic acrylic) 
and CeeOn Edge 911A (Pharmacia & Upjohn Co.) (silicone) IOLs, the glistenings continued 
to increase. 
Another study15 that followed patients up to 50 months postoperatively also 
confirmed increasing amounts of glistenings with time. Two other studies21 32 also reported 
that glistenings increase with time. 
In one in vivo study20 the incidence and severity of glistenings did not increase 
up to 24 months postoperatively. One in vitro study10 showed that glistenings stabilizes after 
a certain time after the IOL was immersed in an aqueous environment.  
 
1.7 GLISTENING IN DIFFERENT IOL MATERIALS 
1.7.1 Glistenings in hydrophobic IOLs 
Hydrophobic acrylic IOLs, especially AcrySof IOLs, have received most attention in 
previous studies of glistenings. The AcrySof MA60BM (Alcon), Sensar AR40e (AMO), 
Acryfold VA-60BB (HOYA), Nex-Acri N4-18B (NiDEK), and Avansee AU (Kowa Co.) 
were studied in vitro for accelerated glistening formation in a laboratory test simulating 20-
year deterioration of acrylic IOLs12. All IOLs but the Avansee AU6 developed glistenings. 
Two other IOLs, XACT X60 (Advanced Vision Science) and enVista MX60 
(Bausch & Lomb), both made of the same material, claimed that no glistenings developed in 
2-year and 6-month follow-up studies33-35. 
1.7.2 Glistenings in hydrophilic IOLs 
There are few studies on hydrophilic acrylic IOLs and glistenings development. Tognetto et 
al.7 evaluated three hydrophilic IOLs: the ACR6D (Corneal Laboratories), Hydroview 
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(Bausch & Lomb), and Stabibag (Ioltech). The three IOLs developed increased mean grades 
of glistenings in 23% to 45% of eyes from 7 to 90 days after implantation and remained 
stable thereafter until the follow-up endpoint at 2 years. 
In a simulated 20-year deterioration test of acrylic IOLs12, the Hydroview 
HP60M (Bausch & Lomb) IOL did not show any opacities. 
Hydrophilic IOLs tend to not develop glistenings as much as IOLs made of 
other materials. One possible reason is that they contain higher amounts of water. Water 
content in hydrophilic IOLs is often more than 18%. In hydrophobic IOLs, the water content 
is usually lower than 1%. A new hydrophobic IOL, the enVista contains 4% water. The 
manufacturer claims that the enVista IOL was glistenings-free in a 6-month follow-up 
study33. If it is still glistening-free over the longer run, then it would be interesting to discuss 
if the water content in hydrophilic IOLs is the main reason for the low incidence and amount 
of glistenings. 
1.7.3 Glistenings in PMMA IOLs 
The first report of glistenings in IOLs in 1984 was based on a PMMA IOL. In a study of the 
progression of glistenings by Wilkins and Olson32, no glistenings were observed the first 3 
years in the Surgidev B20/20 IOL (Surgidev Corporations). After 7 years all IOLs had 
developed glistenings. The frequency and size of glistenings increased with increased follow-
up time. 
Rønbeck et al.13 compared the development of glistenings 12 years 
postoperatively in PMMA, silicone, and hydrophobic acrylic AcrySof IOLs. The study 
showed almost no glistenings in the PMMA IOL, and the amount of glistenings was 
significantly higher in silicone and hydrophobic IOLs than in the PMMA IOL. 
1.7.4 Glistenings in silicone IOLs 
Tognetto et al.7 studied two silicone IOLs, the CeeOn Edge 911A (Pharmacia & Upjohn Co.) 
and the SI-40NB (AMO). Glistenings increased up to 90 days in the SI-40NB IOLs and then 
stabilized. However, the CeeOn® Edge 911A IOL had a continuous increase in the mean 
grade of glistenings at the endpoint of the study 2 years postoperatively. Rønbeck et al.13 
found that the silicone IOL (SI-40NB) developed more glistenings than the PMMA IOL but 
less than the hydrophobic AcrySof IOL 12 years postoperatively. 
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1.8 EFFECT ON VA AND CONTRAST SENSITIVITY 
It seems logical that glistening should adversely affect the CDVA and contrast sensitivity 
because the tiny microvacuoles in the IOL scatter the light passing through the IOL and 
therefore cause deteriorated CDVA or glare. However, no studies up to now support any 
significant correlations between diminished CDVA and glistenings. 
For the examiner, it is obvious when performing neodymium:yttrium-
aluminium-garnet (Nd:YAG) capsulotomy in a patient with an IOL with severe glistenings, 
that it is more difficult to target the laser beam at the posterior lens capsule in the Nd:YAG 
slit-lamp.  
It remains controversial if glistenings affect contrast sensitivity. Most studies 
have not reported any correlation20 28 36 37. However, some studies have shown that contrast 
sensitivity is affected25 and some only at high spatial frequencies27 38. 
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2 POSTERIOR CAPSULE OPACIFICATION 
2.1 INTRODUCTION 
Posterior capsule opacification (PCO) is the most common complication after 
phacoemulsification cataract surgery. The incidence rates range from less than 10% to 50%39-
41. PCO was observed in the early days of IOL implantation at the end of the 1940s. With a 
successively better understanding of the pathogenesis and treatment options for PCO, we can 
now with modern cataract surgery gradually decrease the incidence of PCO with the help of 
better tools39, such as continuous development of safer phacoemulsification machines 
facilitating more thorough cortical removal of lens material, better IOL materials and designs 
that inhibit PCO, and even surgical laser systems to create customized repeatable and perfect 
capsulorhexis sizes, avoiding the unnecessary risk of making too large or off-center 
capsulorhexes and hence decreasing the risk of PCO development42-44.   
Studies have been done with immunotherapy, gene therapy, chemical therapy, 
and physical techniques to eliminate lens epithelial cells (LECs)45-47. 
PCO is still far from eradicated. The only treatment is outpatient Nd:YAG laser 
capsulotomy for cooperative patients. However, because of the total number of cataract 
surgeries annually, it is a societal economic burden48 and Nd:YAG lasers are not readily 
available everywhere, especially in rural areas in developing parts of the world. For the 
patient, Nd:YAG capsulotomy is associated with several sight-threatening complications such 
as retinal detachment49 50, macular edema51, intraocular inflammation50, transient increased 
intraocular pressure (IOP)51 52, increased vitreous opacities53, IOL damage50 54 and IOL 
dislocation55. 
PCO causes symptoms when light passes through the opacified posterior lens 
capsule and is forward-scattered to the retinal fundus. Symptoms such as decreased VA and 
contrast sensitivity, increased glare, diplopia, and blurred images are typical56 57. The 
symptoms may cause disabilities in daily life, for example, when driving a car and especially 
when driving at night. The amount and density of PCO may not be experienced or expressed 
similarly regarding severity by different patients58. The CDVA also can be better or worse 
than expected compared to the PCO status observed by the physician.  
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2.2 PATHOPHYSIOLOGY 
Phacoemulsification cataract surgery removes the opacified lens nucleus and cortex. Two 
types of remnant LECs proliferate and migrate from the equatorial zone of the anterior lens 
capsule (A-cells) or equatorial lens bow (E-cells) toward the central optical zone with time48. 
When LECs are in the central parts of the posterior lens capsule, they scatter light entering 
the posterior segment of the eye causing deteriorated CDVA, glare, and distorted images. A-
cells transformed into myofibroblasts cause fibrosis and shrinking of the anterior lens capsule 
and may lead to IOL tilting and decentration. E-cells have a high capacity for mitosis and 
differentiation into balloon-like bladder cells (Wedl cells) and can form Elschnig’s pearls, a 
regenerative form of lens capsule opacification and the most common PCO, characterized 
clinically as having a pearl-like appearance. A special form of regenerative PCO is 
Soemmerring’s ring, a doughnut-shaped opacity described as early as 1828 with formation of 
Elschnig’s pearls retained at the periphery of the anterior-posterior capsule fuse as a ring-
shaped lesion59. 
 
2.3 FACTORS AFFECTING PCO 
Earlier studies have suggested that age60, uveitis, diabetes mellitus61-65, retinitis pigmentosa66, 
surgery techniques43 44 67, IOL material68-72, and IOL design53 73-77 are PCO-related factors. 
The sharp-edge design of IOLs is probably the most important factor inhibiting 
PCO development74. In a comparative study between two single-piece hydrophilic acrylic 
IOLs78, one IOL was a standard model with a sharp posterior edge except at the optic-haptic 
junctions. The other IOL had an enhanced edge with a peripheral ridge around the lens optic 
360º circumferentially. The latter developed significantly less PCO than the standard model. 
Round-edge IOLs were shown in previous studies to be inferior to sharp-edge 
IOLs in inhibiting PCO74 78-84. The sharp posterior IOL edge acts as a barrier by bending in 
the posterior lens capsule against the sharp posterior square-edge IOL and thus inhibiting 
migration of LECs from the equator of the lens capsule to the central parts of the IOL optic75 
77. 
Nishi et al.74 compared development of PCO between a round-edge and a 
sharp-edge AcrySof IOL and reported that the round-edge IOL developed significantly more 
PCO. The authors concluded that the sharp-edge IOL design was the main PCO inhibitory 
factor and the IOL material instead has a complimentary role in inhibiting PCO 
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development74. Angulation of the IOL haptics enhances the force exerted on the bending 
between the posterior lens capsule and the sharp IOL edge and increases the integrity of the 
barrier85. However, the sharpness of the square-edge IOL can vary between IOLs of different 
materials81 or even the same materials86. Generally, most hydrophilic IOLs have rounder 
edges than hydrophobic IOLs probably because during the manufacturing process 
hydrophilic IOLs are lathe-cut from dehydrated IOL blocks and then polished leading to loss 
of the sharp edge81. However, hydrophilic IOLs with sharp edges also exist. 
Comparisons of IOL materials have shown that hydrophilic IOLs develop PCO 
at higher rates than hydrophobic IOLs, 50.3% in a hydrophilic IOL compared with 4.9% in a 
hydrophobic IOL in a 1-year follow-up study by Heatley et al68. Other studies with 1- to 3-
year follow-ups also have reported similar results69 87 88. Linnola et al.89 90 argued that 
fibronectin bindings between the posterior lens capsule and the IOL surface of hydrophobic 
acrylic IOLs seem to have an important role in inhibiting migration of LECs by increasing the 
barrier effect. However, in studies with more than 3 years of follow-up postoperatively that 
compared hydrophobic acrylic with silicone and PMMA IOLs, the PCO incidence and 
Nd:YAG capsulotomy rates increase in the hydrophobic IOLs are equal to or even surpass the 
rates for silicone IOLs91-93. One theory is that the barrier effect of the sharp posterior edge 
design in acrylic IOLs that inhibit PCO development gradually may be compromised when 
increasing amounts of slowly migrating LECs physically force the reopening of the barrier 
between the IOL edge and posterior lens capsule91 92. 
 
2.4 METHODS TO ASSESS PCO 
Most earlier studies have analyzed PCO with retroillumination images. Several image 
computer software packages are available with their respective advantages and 
disadvantages. Evaluation of Posterior Capsule Opacification software (Augentagesklinik 
Spreebogen) evaluates PCO subjectively. Posterior Capsule Opacification software 
(POCOman, Kings College) evaluates PCO semiobjectively, Posterior Capsule Opacification 
software and Automated Quantification of After-Cataract (Medical University of Vienna) 
processes the PCO images in the computer software to calculate the size of the area at the 
posterior capsule that is affected by PCO and determine the PCO density94-96. 
Nd:YAG laser capsulotomy frequency is considered another important 
parameter for evaluating PCO. This parameter correlates well with the CDVA but has a 
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weaker correlation with the contrast sensitivity97. Scheimpflug images have also been used in 
PCO studies98. 
 Patients who already underwent Nd:YAG capsulotomy cannot be evaluated by any of 
the above-mentioned computer software since there is no posterior capsule. This problem was 
addressed previously99. These patients received the highest scores for PCO area and severity 
in studies I and III. We assumed if they have not had Nd:YAG capsulotomy earlier they 
would have had a high grade of PCO.  
 Long-term studies also have an increased number of patient dropouts with increased 
follow-up time. Patients get older, some die, and some get ill during the follow-ups. 
Information about Nd:YAG capsulotomy frequency becomes uncertain when this 
information only comes from patients living long enough or those healthy enough to 
complete the follow-up examination. It is possible that some dropouts would have had 
Nd:YAG capsulotomy at the follow-up visit if they had arrived for the examination. 
However, the capsulotomy data are only obtained from patients at the follow-up visits. To 
collect as much information as possible from all patients, we used survival analysis, which 
has been used in earlier similar studies13 99. The analysis has the advantage of considering the 
data from patients until they are lost to follow-up. 
 
2.5 PROGRESSION OVER TIME 
PCO frequency has been reported with great variability from 10% to 60% in different studies. 
Since the introduction of IOLs with a sharp posterior edge profile, the PCO frequency can be 
as low as about 10% 5 years postoperatively39 40. 
 Development of PCO in different IOL materials shows different patterns. Two 
follow-up studies100 101 have reported that the Nd:YAG capsulotomy rates increased from the 
2-year to the 5-year follow-up for three different IOLs, a PMMA, a silicone, and a 
hydrophobic acrylic. The Nd:YAG rate increased from 20% to 61% for the PMMA (HSM 
809C) IOL (Pharmacia & Upjohn), 22% to 33% for the silicone (SI-40NB) IOL, and 8% to 
22% for the hydrophobic acrylic (AcrySof MA60BM) IOL.  
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3 FLUIDICS IN PHACOEMULSIFICATION 
 
3.1 INTRODUCTION 
Modern cataract surgery is performed using the phacoemulsification technique102 103. This 
technique has the advantages of small incision wounds, faster sight rehabilitation, less 
damage to the intraocular tissues, and minimal intraoperative and postoperative complications 
compared to previous surgical techniques104-107. 
To extract the opacified lens with a diameter of about 10 millimeters through a 
2- to 3-millimeter incision, the lens is divided into smaller fragments. This is done with the 
phacoemulsification tip inserted through the incisional wound to divide the lens into smaller 
fragments and aspirate the lens fragments through the tip opening. The tip uses ultrasound 
energy to emulsify the lens, builds up heat in and around the tip, and can damage the 
surrounding tissues. The tip also has two other functions, i.e., irrigation and aspiration. 
Irrigation helps cool the heat around the tip by producing an inflow of saline solution that 
dilutes the heat near the tip. Aspiration also maintains stabilized fluid volume in the anterior 
chamber and drains excess heat from the eye. Lens fragments follow the irrigating fluid flow 
to the opening of the tip. When lens material fully occludes the tip opening, the machine then 
uses vacuum to crush and suck (i.e., aspirate) the material into a waste bag in the machine 
through the hand-piece connected to the tip. Modifying the irrigation and aspiration settings 
in the phacoemulsification machine can create different effects to enhance and facilitate a 
smooth surgical procedure. The surgeon may ensure a surgery with a stable anterior chamber 
and good followability by changing the settings for different anatomic variations in eyes or 
different hardnesses of the lens nucleus. Most surgeons have their own settings during the 
different surgical phases: sculpting, lens consumption and removal of remaining lens cortex. 
However, some questions remain unanswered. Some surgeons claim that minimizing fluid 
turbulence intraoperatively may cause less surgical trauma to the eye compared to the 
standard settings most surgeons use. However, few studies have been conducted in this 
field108 109.  
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3.2 PARAMETERS INDICATING SURGICAL TRAUMA 
We know from earlier studies that a large amount of ultrasound energy is dissipated from the 
phacoemulsification tip and increases the possibility of a cornea with more swelling110, 
anterior chamber reaction111-114, cystoid macular edema (CME)115 116, increased postoperative 
IOP, and decreased corneal endothelial cell density (ECD)108.  
 
3.3 METHODS TO MEASURE THE PARAMETERS INDICATING SURGICAL 
TRAUMA IN PHACOEMULSIFICATION 
The central corneal thickness (CCT) can be measured by different pachymetric methods117-
119. Most often optical or ultrasound diagnostic tools are used. The examiner can visually 
detect CME, but posterior-segment optical coherence tomography (OCT) can be performed 
to quantify and compare the results120. ECD measurements can be obtained with confocal 
microscopy121. An anterior chamber reaction can be detected and quantified with a flare 
meter111 122 123. 
 
3.4 EFFECT ON VISION 
Increased CCT, CME, anterior chamber reaction, high IOP, and decreased ECD are all 
factors that can solely or in combination cause diminished CDVA. 
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4 GENERAL AIMS 
 
In study I, our goal was to determine if two hydrophobic acrylic IOLs develop PCO and 
glistenings differently and if glistenings affected VA and contrast sensitivity 5 to 7 years after 
phacoemulsification cataract surgery. 
In study II, we evaluated a hydrophobic and a hydrophilic acrylic IOL and 
compared the development of glistenings and the impact on VA and contrast sensitivity in the 
IOLs 9 years after phacoemulsification cataract surgery. 
In study III, we evaluated the same hydrophobic and hydrophilic acrylic IOLs 
as in study II and compared the development of PCO and survival without Nd:YAG 
capsulotomy in the IOLs 9 years after phacoemulsification cataract surgery. 
In study IV, we compared two different fluidic settings in phacoemulsification 
cataract surgery and the impact on postoperative parameters. 
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5 MATERIALS AND METHODS 
 
5.1 STUDY I 
5.1.1 Study design 
The 80 patients who underwent cataract surgery from 2002 to 2005 in this prospective study 
were randomized into two equal groups of 40 patients each. One group received the three-
piece Sensar AR40e IOL and the other group received the one-piece AcrySof SA60AT IOL; 
both IOLs are made of a hydrophobic acrylic material with a sharp posterior IOL edge 
design. The patients were contacted for a follow-up visit during 2010. The CDVA 
measurements obtained with the 100% and 2.5% Early Treatment Diabetic Retinopathy 
Study (ETDRS) charts were recorded in the logarithm of the minimum angle of resolution 
scale. We obtained retroillumination images of PCO with a fundus camera and Scheimpflug 
images of glistenings with the Pentacam HR (OCULUS Inc.).  
The retroillumination images of PCO were loaded into a posterior capsule 
opacity computer software system (POCOman) and calculated semiobjectively, because 
some steps in the analysis required manual interactions. The program applied a grid pattern 
on the retroillumination images and divided the area into 56 approximately equal sectors. The 
area outside the capsulorhexis was excluded from analysis. The examiner marked any sector 
with PCO covering more than 50% of the area and graded the severity of PCO as 0 indicating 
no PCO, 1 mild, 2 moderate, and 3 severe. The software then calculated the overall severity 
of the PCO ranging from 0 to 3 and the total area of the PCO as a fraction of the affected area 
divided by the total area within the capsulorhexis (figure 2).  
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Figure 2. POCOman software quantifies PCO area 
and severity. 
  
 
Quantitative glistening analysis was conducted objectively by loading two 
Scheimpflug images, a superior and a temporal camera position, of the IOL into ImageJ 
image analysis software (National Institute of Health). A small rectangular box comprised of 
the entire IOL thickness and including the area anterior and posterior to the IOL within the 
central 1.5 millimeters zone of the visual axis was selected for analysis (figure 3). The raw 
data extracted from the software were subsequently imported into a macro in Excel software 
(Microsoft Corp.) to perform the calculations. The macro was written to calculate the light 
scattering in the IOL and calibrate it against the minute light scattering in the aqueous humor. 
The peak light scattering in the posterior part of the IOL was interpreted as the posterior lens 
capsule and not included in the calculations. The output result was the amount of glistenings 
in arbitrary units. 
 
 
 
 
 
The examiner scores the severity 
of PCO for any sector with more 
than 50% of the area affected by 
PCO using color codes. No 
markings indicate 0, blue 1, 
yellow 2, and red 3. 
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Figure 3. Selecting the area of interest in glistening analysis. The yellow box, placed within 
the central 1.5 mm zone of visual axis, is the area selected for glistening analysis. The green 
arrow indicates the anterior IOL surface; the red arrow indicates the posterior IOL surface. 
 
 
We analyzed glistenings in three ways: the full IOL thickness, as deep 
glistenings by subtracting the light scattering in the Scheimpflug images in the 73 microns 
of the most anterior part and the 73 microns of the most posterior part of the IOL from the 
total amount of the light scattering in the full IOL thickness, and as very deep glistenings 
by subtracting the light scattering in the 103 microns of the most anterior part and the 103 
microns in the most posterior part of the IOL from the total amount of light scattering in 
the full IOL thickness. The calculations with the two last-mentioned ways omitted the light 
scattering from the anterior and posterior IOL surfaces, which omits surface light 
scattering from the calculations.  
Subjective gradings of the glistenings at the slit-lamp microscope were 
recorded according to a grading system with scoring from 0 to 3, with 0 indicating no 
glistening, 1 trace, 2 moderate, and 3 severe. 
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5.1.2 Inclusion and exclusion criteria 
Patients 39 to 86 years old with cataracts were included. Patients were excluded who had 
moderate or advanced age-related macular degeneration, corneal pathology, earlier retinal 
photocoagulation, diabetes mellitus, glaucoma, exfoliation syndrome, and uveitis, and those 
who received preoperative oral steroid therapy or underwent a previous intraocular surgery. 
5.1.3 Surgery 
One experienced surgeon performed the cataract surgery using phacoemulsification with a 
clear corneal incision. The surgical procedure was initiated with topical and intracameral 
anesthesia. Sodium hyaluronate was used as an ophthalmic viscosurgical device (OVD). 
Continuous capsulorhexis was followed by hydrodissection with balanced saline solution 
(BSS) and phacoemulsification in the capsular bag. Irrigation and aspiration of the remaining 
cortex were performed and one of the two IOLs was folded and injected into the capsular bag. 
The procedure ended with an intracameral injection of cephalosporin as antibiotic 
prophylaxis, and the corneal wound was hydrated with BSS using a blunt injection needle. 
The patients instilled topical dexamethasone in a tapering dose during the first 3 
postoperative weeks. 
5.1.4 Statistical analysis 
Quantitative comparisons of the PCO area and severity and the amount of glistenings were 
analyzed with the Mann-Whitney U-test. Nd:YAG capsulotomy rates to compare the two 
IOLs were calculated using Fisher’s exact two-tailed test. All calculations for correlations 
were conducted with the Spearman rank-order correlation. 
 
5.2 STUDY II 
5.2.1 Study design 
This was a prospective randomized study that included 120 patients, who had 
phacoemulsification cataract surgery between 2002 and 2004. The patients were randomized 
to one of two groups and received either the hydrophilic BL27 IOL or the hydrophobic 
AcrySof SA60AT IOL, both of which were one-piece acrylic IOLs with sharp posterior 
edges. Nine year after surgery the patients were contacted for a follow-up examination. 
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Lens glistening analysis was conducted in the same way as in study I with 
Scheimpflug images with subsequent data processing using computer software for objective 
quantification and grading at the slit-lamp for subjective scoring. 
The CDVA and contrast sensitivity were measured using the Optec® 6500 
Vision Tester (Stereo Optical Co., Inc.), with an ETDRS chart for the CDVA 
measurements and Functional Acuity Contrast Test (F.A.C.T, Stereo Optical Co., Inc.) for 
the contrast sensitivity measurements. The F.A.C.T is a sine-wave grating chart that tests 
the functional VA in five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree) and 
nine levels of contrast. The patient determined the minimal contrast grating level seen for 
each spatial frequency. The last correct grating level identified for each spatial frequency 
was plotted on a contrast sensitivity curve. The area under the curve value was used in the 
statistical analysis to determine any correlation with the amount of glistenings. This 
method of measuring the contrast sensitivity is more accurate than other available contrast 
sensitivity measurements124. The contrast sensitivity measurements were conducted with 
and without glare. When testing with glare, 12 light-emitting diode lamps were arranged in 
an oval arc around the testing field and lighted.  
5.2.2 Inclusion and exclusion criteria 
Patients 60 to 90 years old with senile cataracts were included. Patients were excluded who 
had a dilated pupil less than 6 millimeters; a previous history of intraocular surgery, corneal 
endothelial damage, or ocular trauma; traumatic cataract; pseudoexfoliation syndrome; 
uveitis; diabetic retinopathy; glaucoma; or advanced macular degeneration; and those 
receiving long-term anti-inflammatory treatment. 
5.2.3 Surgery 
One of three experienced surgeons performed the phacoemulsification surgeries. The surgical 
procedures were the same as described for study I. 
5.2.4 Statistical analysis 
The follow-up time between the two IOLs was compared using the Student’s t-test. The 
comparison of the amount of glistenings associated with the two IOLs was calculated with 
the Wilcoxon rank-sum test. The correlations between glistenings, CDVA, and contrast 
sensitivity were analyzed using the Spearman rank-order correlations. 
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5.3 STUDY III 
5.3.1 Study design 
The study design was the same as described for study II.  
The PCO area and severity analyses were conducted with POCOman software in the same 
way as in study I. The survival time without Nd:YAG laser capsulotomy was recorded and 
defined as the time from the date of surgery to that of Nd:YAG laser capsulotomy. 
5.3.2 Inclusion and exclusion criteria 
The inclusion and exclusion criteria were the same as in study II. 
5.3.3 Surgery 
The surgical procedures were the same as described for study II. 
5.3.4 Statistical analysis 
The comparisons of the follow-up time and average age at surgery between the two groups 
were calculated with the Student’s t-test. The Mann-Whitney U-test was used to compare the 
PCO area and severity. The Gehan-Wilcoxon test and log-rank test were used to calculate the 
survival rate without Nd:YAG capsulotomy. 
 
5.4 STUDY IV 
5.4.1 Study design 
This prospective randomized study included 43 patients who underwent phacoemulsification 
cataract surgery from 2012 to 2015 at St. Erik Eye Hospital. Patients were randomized to 
torsional phacoemulsification performed using the Infiniti Vision System (Alcon Inc.); the 
stop-and-chop technique was used with either low or standard fluidic settings. The low-
settings group had the bottle height and aspiration parameters of the phacoemulsification 
machine at about half the standard settings and vacuum at 73% of the standard settings, 
which diminishes the fluid turbulence in the anterior chamber and the IOP levels 
intraoperatively. The amount of saline used intraoperatively, the duration of surgery, and the 
cumulative dissipated energy (CDE) were recorded. The parameters indicating surgically 
induced trauma were measured preoperatively as reference values and compared with the 
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values at the postoperative follow-up visits on 1 day, 3 weeks, and 3 months postoperatively. 
The measurements included the CDVA tested with the ETDRS chart, IOP measured by 
Goldmann applanation tonometry, macular thickness measured on posterior-segment OCT 
images, CCT measured on anterior-segment OCT images, ECD using confocal microscopy, 
and anterior chamber flare using a laser flare meter.  
5.4.2 Inclusion and exclusion criteria 
Patients 50 to 85 years old with cataracts were included. The exclusion criteria were the same 
as in studies I-III with addition of traumatic, extremely dense cataract or subluxated lenses; 
an anterior depth shallower than 2.1 millimeters, pupillary dilation with cyclopentolate-
phenylephrine less than 5 millimeters, previous retinal photocoagulation, ECD less than 
1,500 cells/mm2 and medical treatment with corticosteroids or non-steroidal anti-
inflammatory drugs. 
5.4.3 Surgery 
One cataract surgeon performed standard torsional phacoemulsification using the Infiniti 
Vision System. The procedure began with creation of a clear corneal incision, followed by 
administration of intracameral anesthesia and a cohesive OVD (1.5% sodium hyaluronate, Z-
HYALIN plus, Carl Zeiss Medical AG). A continuous capsulorhexis and subsequent 
hydrodissection with BSS and phacoemulsification in the capsular bag and irrigation and 
aspiration of the remaining lens cortex with BSS using an instrument tip were performed. An 
acrylic hydrophobic IOL, the AcrySof IQ SN60WF, was folded and injected into the capsular 
bag followed by OVD removal. The corneal wound was hydrated with BSS using a blunt 
injection needle. The procedure ended with an intracameral injection of moxifloxacin as 
antibiotic prophylaxis. The patients instilled topical dexamethasone three times daily in a 
tapering dose during the first 3 postoperative weeks. 
5.4.4 Statistical analysis 
Normally distributed data were analyzed with the Student’s t-test to compare the groups and 
the paired t-test to compare within the groups. Non-parametric data analysis was conducted 
with the Wilcoxon rank-sum test to compare two groups, and the postoperative differences 
were compared to the preoperative values within the group with repeated measure analysis of 
variance (Friedman) and the Wilcoxon signed-rank test. 
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The means and SDs in parametric data and medians with lower and upper 
quartiles for the measured non-parametric data were calculated for both groups. 
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6 RESULTS 
6.1 STUDY I 
6.1.1 Patient data 
The study included 80 patients divided evenly between two groups. Fifty-six patients 
completed a follow-up visit between 5 to 7 years after phacoemulsification cataract surgery. 
The average age of the patients at surgery was 68.2 years ± 9.7 (SD) (range, 39-86 years). 
6.1.2 PCO and Nd:YAG capsulotomy 
There were no significant (P>0.05 for all comparisons) differences between the groups in 
PCO area and severity or Nd:YAG capsulotomy. 
6.1.3 Glistenings 
The AcrySof SA60AT IOL developed significantly more glistenings detected by quantitative 
Scheimpflug image analysis compared to the Sensar AR40e IOL not only when the full 
thickness of the IOL was analyzed but also when deep glistenings and very deep glistenings 
were compared between the two IOLs (P<0.001 for all 3 comparisons) . Similar results were 
also observed when obtaining the data based on the subjective gradings of glistenings at the 
slit-lamp microscope. No glistenings were seen in 24 of 27 IOLs and mild glistenings in the 
remaining three IOLs in the Sensar AR40e IOL group. The AcrySof IOL was characterized 
by even distribution of glistening severity, but more of these IOLs had mild glistenings. The 
quantitative analysis of glistenings using Scheimpflug images was correlated with the 
subjective gradings of glistenings (R=0.61; P<0.05). The IOL power, contrast sensitivity, or 
CDVA were not correlated with the amount of glistenings (R=0.13, P>0.05; R=0.16, P>0.05; 
and R=0.1, P>0.05, respectively). 
 
6.2 STUDIES II AND III 
6.2.1 Patient data 
Study II included 120 patients divided evenly into two groups. The mean patient age was 
72.8 years ± 6.7 years (SD) (range, 60-84 years) at surgery. At the 9-year follow-up visit, 78 
patients, 42 in the hydrophilic BL27 group and 36 in the hydrophobic AcrySof SA60AT 
group, completed the examination.  
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6.2.2 Glistenings 
The hydrophobic AcrySof SA60AT IOL developed a significantly higher amount of 
glistenings compared to almost no glistenings in the hydrophilic BL27 IOL based on 
quantitative analysis in 3 different IOL depths (full thickness, deep glistenings and very deep 
glistenings) with Scheimpflug images (P<0.001, for all 3 comparisons). Subjective grading of 
glistenings by slit-lamp microscopy showed evenly distributed severity scores of 0 to 3 (0 
indicates no glistenings, 1 trace, 2 moderate, 3 severe) in the hydrophobic AcrySof SA60AT 
IOL and only grade 0 for all hydrophilic BL27 IOLs. There were no correlations between the 
glistenings and contrast sensitivity (R=-0.25, P>0.05), CDVA (R=0.06, P>0.05), or IOL 
power (R=-0.0086, P=0.96). 
6.2.3 PCO 
There were no significant differences in the CDVA between the groups (P>0.05). The median 
survival time without Nd:YAG capsulotomy was 2.6 years in the hydrophilic BL27 group 
and over 9 years in the hydrophobic AcrySof SA60AT IOL. The survival rates without 
Nd:YAG capsulotomy did not differ significantly regarding gender, operated eye, or patient 
age at surgery (P>0.05 for all comparisons). 
 Study III was an extended follow-up study at 9 years. Data from earlier follow-ups69 
125 at 1 and 2 years postoperatively were retrieved to compare how the PCO developed. The 
results (table 1) show that values increased for both IOLs, but the hydrophilic IOL had an 
accelerated increase of Nd:YAG capsulotomies, PCO area, and PCO severity between 1 to 2 
years postoperatively compared to the hydrophobic IOL.  
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Table 1. Summary of cumulative Nd:YAG capsulotomy rate, PCO area, and severity at the 1-
, 2-, and 9-year follow-up visits. 
Parameters 
 
Cumulative 
Nd:YAG rate 
(%) 
 
PCO area (%) (Median) 
 
PCO severity (Median)
Follow-up 
 
AcrySof 
SA60AT 
IOL 
 
BL27 
IOL 
 
 
AcrySof 
SA60AT 
IOL 
 
 
BL27 
IOL 
 
 
AcrySof 
SA60AT 
IOL 
 
 
BL27 
IOL 
1 year 5 3 4.65 18.2 0.055 0.18 
2 year 10 40 4.5 46 0.045 0.74 
9 year 28 67 13.4 (0-100)† 100 (49-100)† 0.26 (0-3)† 3 (1-3)† 
†=range lower to upper quartile 
 
6.3 STUDY IV 
6.3.1 Patient data 
Forty-three patients were included in this prospective randomized study, 21 in the standard-
settings group and 22 in the low-settings group. Measurements performed 3 weeks and 3 
months postoperatively in one patient in the standard-settings group were excluded from the 
calculations because the patient needed treatment with an oral nonsteroidal anti-inflammatory 
drug for another disease. 
6.3.2 Fluidics and the impact on postoperative parameters 
There were no significant differences between the groups regarding the postoperative 
parameters CDVA, CCT, anterior chamber flare, IOP, macular thickness, or ECD up to 3 
months after phacoemulsification cataract surgery (P>0.05 for all comparisons). The surgical 
time was significantly longer (P<0.01) and the CDE was significantly higher (P<0.001) in the 
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group with low fluidic settings. The median surgical time in the standard-settings group was 7 
minutes and 20 seconds and 8 minutes and 28 seconds in the low-settings group. The mean 
CDE was 7.61 ± 3.61 (SD) in the standard-settings group and 15.14 ± 5.0 (SD) in the low-
settings group.  
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7 DISCUSSION 
 
7.1 STUDIES I-III 
7.1.1 Lens glistenings 
Different hydrophobic IOLs do not develop glistenings to the same extent as we 
showed that the AcrySof IOL did in study I. The hydrophobic AcrySof IOL developed much 
more glistenings as Tognetto et al.7 reported earlier in a glistening study that evaluated 
AcrySof IOLs compared to another hydrophobic IOL. The investigators compared 
development of glistenings in seven different IOLs, two (AcrySof and Sensar) were 
hydrophobic acrylic IOLs. The AcrySof IOL showed a continuous increase in glistenings 
over 2 years and more glistenings than the Sensar IOL.  
An in vitro study12 that simulated 20-year deterioration of IOLs included six 
different hydrophobic acrylic IOLs, AcrySof MA60BM, AcrySof SA60AT, Sensar AR40e, 
Acryfold VA-60BB, Nex-Acri N4-18B, and Avansee AU6, showed that only the last IOL did 
not develop glistenings. The authors described the characteristics of glistening development 
in each IOLs, but they did not rank them. 
Study II compared one hydrophobic IOL with a hydrophilic IOL 9 years 
postoperatively and showed that the hydrophilic IOL was not prone to glistening 
development even over the long term. This agreed with an earlier short-term follow-up study 
conducted for hydrophilic IOLs7. No other in vivo study of glistening development in 
hydrophilic IOLs has been conducted until now. 
The severity of glistenings development in one in vitro study simulating 
accelerated 20-year IOL deterioration included a series of hydrophobic IOLs12. The tendency 
was that IOLs with higher water content developed fewer glistening-like opacities. 
Another issue is the differences in refractive indices between the hydrophobic 
IOLs we studied, 1.55 for the AcrySof IOL and 1.47 for the Sensar AR40e IOL. Aqueous 
humor has a refractive index of 1.336, which is very close to that of water (1.333). When 
differences in refractive indices between two media (i.e., IOL material and water) increase, 
the amount of reflected light rays also increases according to Snell’s law126. The higher 
refractive index in the AcrySof IOL compared to the refractive index of the Sensar IOL also 
may make glistenings more visible at the slit-lamp and in the Scheimpflug images. 
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To quantify glistenings in IOLs, we used Scheimpflug images in studies I and 
II. This method has been described earlier23 29 and also was positively correlated with slit-
lamp gradings14. Study I agreed with this study and found a correlation between quantified 
analyses of glistenings using Scheimpflug images with subjective slit-lamp grading of 
glistenings. 
Surface light scattering and PCO are two potential sources of error when 
analyzing glistenings with Scheimpflug images, because these two phenomena also can be 
seen in the images as whitish bands of light scatterings in the IOL anterior and posterior 
surfaces. Eliminating these two phenomena from the calculations can be accomplished by 
omitting light scattering values from the IOL anterior and posterior surfaces, thus only light 
scatterings within the IOL (i.e., glistenings) are analyzed. We analyzed glistenings in the 
central parts of the IOL by subtracting light scattering from 73 microns and 101 microns from 
the IOL anterior and posterior surfaces and referred to them as deep and very deep 
glistenings, respectively. Excluding cases with PCO in the visual axis is another way to be 
certain to not include PCO in the calculations. Scheimpflug images appear to be a valuable 
and reliable tool and until now the only method to quantify glistenings objectively. 
The CDVA and contrast sensitivity (studies I and II) were not correlated with 
the amount of glistenings as in most earlier studies7 15 20 28 37 127 128. The IOL dioptric power 
was not correlated with glistenings in studies I and II. The results from earlier studies are 
inconclusive; some show correlations with glistenings13 15 17 20 129 and some do not128 130. 
A weakness of the studies was the large number of patient dropouts, i.e., 30% 
in study I and 35% in studies II and III. Long-term follow-up studies have this problem 
because patients become older and die, get ill, or move. 
 
7.1.2 PCO 
Long-term follow-up studies of PCO (studies I and III) are important because the average 
patient with an IOL is likely to have it for about 10 years, since the average age at surgery in 
many studies of patients with senile cataracts is 68 to 73 years. The average lifespan in 
Sweden was 83.7 years for women and 80.1 years for men in 2013 according to Statistics 
Sweden (Statistiska centralbyrån)131, an authority in Sweden. We have seen cases in which 
the long-term follow-up of PCO development has yielded surprising results. One example 
was that the sharp posterior edge design in a hydrophobic acrylic IOL inhibits PCO more 
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effectively for the first 3 to 5 years compared to a silicone IOL with a round-edge design100. 
After 12 years, the rates of PCO development and Nd:YAG in sharp-edge IOLs catch up with 
the round-edge IOLs93. Two other studies have reported similar results with loss of the 
advantageous PCO inhibitory features compared to silicone IOLs 6 years postoperatively91 92. 
In study I, we compared two hydrophobic acrylic IOLs with a sharp-edge 
design for PCO development. To our knowledge, this study had the longest follow-up time 
for comparing two different hydrophobic IOLs for PCO development. There were no 
significant differences in PCO area, severity, or Nd:YAG capsulotomy rates between the 
IOLs 5 to 7 years postoperatively and the study had results similar to other studies with 
shorter follow-up times132-136. 
In study III, we compared PCO development between a hydrophilic IOL 
(BL27) and a hydrophobic IOL (AcrySof SA60AT) 9 years postoperatively. This study had 
the longest follow-up time comparing PCO development between hydrophilic and 
hydrophobic acrylic IOLs. We concluded that the advantageous PCO inhibitory effect in the 
hydrophobic IOL at 2 year postoperatively remained valid even after 9 years. The superior 
PCO inhibitory characteristics of the hydrophobic acrylic IOL may depend on many different 
factors, i.e., the sharp-edge IOL profile and the stronger bindings of the AcrySof IOL to the 
posterior capsule. Strong binding of the posterior capsule to the posterior IOL surface 
minimizes any space for LECs to grow into the posterior capsule according to the concept of 
“no space, no cells”48. The hydrophobic AcrySof SA60AT IOL has these characteristics43 74-
76. We mentioned previously that the sharp-edge hydrophilic IOLs generally are not as sharp 
as hydrophobic IOLs mostly due to different manufacturing techniques. The edge sharpness 
of BL27 IOL has not been studied earlier. It is then difficult to determine if the primary 
superior PCO inhibitory factor is the sharp-edge design or the strong fibronectin binding in 
our study. But earlier study74 support the sharp-edge IOL profile as the most important factor 
inhibiting PCO development. 
In study III, we also compared Nd:YAG capsulotomy rates between two 
different IOLs with survival analysis. Long-term follow-up studies usually have many patient 
dropouts and simply comparing Nd:YAG numbers becomes unreliable. The advantage in 
survival analysis is that all patient data are valuable and can be used up to the point at which 
they are lost to follow-up.     
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7.2 STUDY IV 
The study results were interesting, because it was unexpected that lower fluidic settings did 
not have any substantial benefits compared to standard fluidic settings concerning 
postoperative parameters indicating surgical trauma. The disadvantages with low fluidic 
settings were a significantly longer surgical time and use of more CDE.  
Few studies have been conducted in this field. Two earlier studies have 
investigated fluidic levels and the impact on the eye. Baradaran-Rafii et al.108 compared low 
versus high aspiration parameters in longitudinal phacoemulsification. Their fluidic 
parameters were almost the same as ours, except that our vacuum levels were higher. Those 
investigators concluded that decreased ECD postoperatively was related to CDE. Increased 
CDE yielded decreased ECD. One important difference between our and their study was that 
we used torsional phacoemulsification, which is more effective than longitudinal 
phacoemulsification in lens aspiration137-144, and it produces less heat138 145 with less increase 
in postoperative corneal thickness143 144 and less endothelial cell loss143. 
Vasavada et al109 found a lower increase in CCT 1 and 7 days postoperatively 
with low fluidic settings compared with high fluidic settings. Those investigators had higher 
CDE for both fluidic settings groups compared to our study. They used the Infiniti Vision 
System as we did, but the difference was that they performed longitudinal 
phacoemulsification. 
We cannot state to what extent torsional phacoemulsification plays a role and 
results in no significant differences in the postoperative parameters. Probably the duration of 
surgery, CDE amount, and fluidic levels are important factors. However, the purpose of our 
study was not to determine any threshold levels for tissue damage for the respective factors. 
More studies are needed in the future to establish these correlations. We can conclude that in 
normal daily cases with senile cataracts, there were no significant differences in the 
postoperative parameters between standard fluidic and low fluidic settings in 
phacoemulsification cataract surgery. The low fluidic settings were a bit disadvantageous 
because of the extended surgical time and the demand for a higher amount of ultrasound 
energy. 
A weakness in this study was the small number of patients. With more patients, 
significant differences may be seen that we were unable to detect.  
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8 MAIN CONCLUSIONS 
 
In study I, the AcrySof SA60AT IOL developed significantly more glistenings than the 
Sensar AR40e IOL, both hydrophobic acrylic IOLs, 5 to 7 years after phacoemulsification 
cataract surgery. Development of PCO area and severity and the frequency of Nd:YAG laser 
capsulotomy did not differ between the AcrySof SA60AT and Sensar AR40e IOLs 5 to 7 
years postoperatively. 
In study II, the AcrySof SA60AT IOL, a hydrophobic acrylic IOL, developed 
significantly more glistenings compared to the BL27 IOL, a hydrophilic acrylic IOL, 9 years 
after phacoemulsification cataract surgery. 
In study III, the AcrySof SA60AT IOL had a significantly longer survival time 
without Nd:YAG laser capsulotomy compared to the BL27 IOL, 9 years after 
phacoemulsification cataract surgery. 
In study IV, there were no significant differences in the postoperative 
parameters indicating surgical trauma between the standard and low fluidic settings in 
phacoemulsification cataract surgery. However, the surgical time was longer in the low-
fluidic-settings group, and more phacoemulsification energy was needed to aspirate the lens. 
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9 FUTURE PERSPECTIVES 
 
Thus far, glistenings have not been a big issue in relation to symptomatic complaints from 
patients who have undergone phacoemulsification cataract surgery. Is it necessary to further 
investigate this matter? In my opinion, it is certainly worth the effort, because according to 
the studies, glistenings may increase with time. The average lifespan has been increasing for 
many years in Sweden and worldwide, and the average patient age for IOL implantation 
during cataract surgery is slightly lower than before, i.e., 76 years in 1999 compared to 74 
years in 2013 (Swedish National Cataract Registry annual report 2013)146. This means that 
the average patient is going to have their IOL for a longer period and the possibility for 
developing glistenings and PCO also increases. 
In most cases, patients only undergo IOL implantation once because of the risk 
of complications when trying to explant the old IOL and re-implant a new IOL. Therefore, it 
is important that we implant the most satisfactory IOLs initially. That includes lowering the 
rates or if possible even eradicating glistenings and PCO to maximize the chances of the best 
postoperative outcomes. 
In our studies, the average patient age was about 70 years. However, there is an 
increasing market for presbyopic refractive surgery due to the popularity and potential with 
gradually safer phacoemulsification machines, improved surgical techniques, and better IOL 
materials. These patients are often younger than most patients in the studies of glistenings and 
PCO and they are still in the workforce, tend to have better CDVA and contrast sensitivity 
preoperatively, and are more demanding of perfect results. If the contrast sensitivity decreases 
only slightly in this group, it may be enough to lead to visual symptoms and complaints. It is 
not rare that the implanted IOLs in these patients are premium IOLs with toric and multifocal 
characteristics. Performing Nd:YAG capsulotomy in patients with these lenses is best 
avoided if possible. Potential complications of Nd:YAG capsulotomy such as IOL dislocation 
and tilting with IOL decentration may cause more pronounced visual symptoms compared to 
monofocal IOLs.  
Multifocal IOLs decrease contrast sensitivity by about 20% compared to 
standard monofocal IOLs147-151. Could this reduction in contrast sensitivity in a younger 
group of patients together with development of glistenings reach a threshold level at which 
visual symptoms occur and is this a new group of patients we should expect to see in the 
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ophthalmology wards in a few years? I think it would be interesting to investigate the 
development of glistenings in premium IOLs and their impact on CDVA and contrast 
sensitivity. 
Many different methods have been used to decrease the PCO rates. However, is 
it possible to eradicate it or further decrease PCO rates? Studies by Tassignon et al.152 153, 
using the so-called bag-in-the-lens technique with a posterior capsulorhexis, have shown 
promising results, but creating a posterior capsulorhexis in the center and with almost the 
same diameter every time can be challenging. Could the new femtosecond laser surgical 
technique be helpful? Study of PCO development using the bag-in-the-lens technique with a 
femtosecond laser also may be worth considering, making an eventual second visit for 
Nd:YAG capsulotomy obsolete. With even better knowledge in these fields of research, we 
can provide feedback to the IOL and surgery machine manufacturers and they in turn can 
develop even better IOLs and machines and minimize intraoperative and postoperative 
complications. 
There are new commercially available phacoemulsification machines that claim 
to control the anterior chamber depth and an IOP more stable than before. It would be 
interesting to study the fluidic settings and the impact on postoperative parameters when the 
IOP can be maintained at a stable and almost fix level throughout the entire surgery, allowing 
further study of different factors and their respective impact on the eye. 
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